survey on the evaluation and management of dlbcl following suboptimal response to car-t therapy
Published 1 year ago • 50 plays • Length 7:35Download video MP4
Download video MP3
Similar videos
-
1:50
outcomes of patients with dlbcl following asct and/or car-t
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
0:43
the development of a composite comorbidity index to predict car-t outcomes in patients with dlbcl
-
1:31
car-t therapy versus autosct in dlbcl
-
1:33
management of relapse after car-t in patients with b-cell lymphoma
-
3:04
applying molecular understanding of dlbcl to management strategies
-
3:47
can car-t cells replace asct in dlbcl?
-
0:42
targeted therapies for dlbcl treatment
-
1:34
updated bsh guidelines for managing dlbcl
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
1:09
interim analysis of anbal-cel for r/r dlbcl
-
2:41
an overview of the latest advances in hematology
-
3:35
outcomes of patients with dlbcl who relapse early following r-ice chemoimmunotherapy
-
1:16
insights into an oncology simulation model being used to evaluate treatment regimens in hl
-
8:24
hrqol, diagnosis and treatment experiences of patients with al amyloidosis: a survey by mpe
-
1:18
estimating long-term outcomes in patients with chl using an oncology simulation model
-
1:21
novel approaches to harnessing the immune system in lymphoma